Cargando…

The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule

CD8+ T cells are crucial for anti-viral immunity; however, understanding T cell responses requires the identification of epitopes presented by human leukocyte antigens (HLA). To date, few SARS-CoV-2-specific CD8+ T cell epitopes have been described. Internal viral proteins are typically more conserv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szeto, Christopher, Chatzileontiadou, Demetra S.M., Nguyen, Andrea T., Sloane, Hannah, Lobos, Christian A., Jayasinghe, Dhilshan, Halim, Hanim, Smith, Corey, Riboldi-Tunnicliffe, Alan, Grant, Emma J., Gras, Stephanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825995/ https://www.ncbi.nlm.nih.gov/pubmed/33521593 http://dx.doi.org/10.1016/j.isci.2021.102096

Ejemplares similares

Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR
por: Szeto, Christopher, et al.
Publicado: (2021)

Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides
por: Chatzileontiadou, Demetra S.M., et al.
Publicado: (2021)

Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition
por: Szeto, Christopher, et al.
Publicado: (2020)

Homologous peptides derived from influenza A, B and C viruses induce variable CD8 (+) T cell responses with cross‐reactive potential
por: Nguyen, Andrea T, et al.
Publicado: (2022)

CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses
por: Lineburg, Katie E., et al.
Publicado: (2021)

Protective HLA-B57: T cell and natural killer cell recognition in HIV infection
por: Lobos, Christian A., et al.
Publicado: (2022)

The Many Faces of CD4(+) T Cells: Immunological and Structural Characteristics
por: Chatzileontiadou, Demetra S. M., et al.
Publicado: (2020)

HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure
por: Khor, Seik-Soon, et al.
Publicado: (2021)

HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
por: Kutszegi, Nóra, et al.
Publicado: (2017)

The pockets guide to HLA class I molecules
por: Nguyen, Andrea T., et al.
Publicado: (2021)

Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice
por: El Bissati, Kamal, et al.
Publicado: (2020)

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02
por: Martín, Paloma, et al.
Publicado: (2015)

HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children
por: Amstutz, Ursula, et al.
Publicado: (2013)

Associations of HLA‐C*01:02 and HLA‐B*46:01 with regorafenib‐induced erythema multiforme in Japanese patients with metastatic colorectal cancer
por: Fujita, Ken‐ichi, et al.
Publicado: (2023)

Two tagging single‐nucleotide polymorphisms to capture HLA‐DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype associated with asparaginase hypersensitivity
por: Kutszegi, Nóra, et al.
Publicado: (2020)

Independent association of HLA-DPB1*02:01 with rheumatoid arthritis in Japanese populations
por: Furukawa, Hiroshi, et al.
Publicado: (2018)

Rapid Multiplex Genotyping of 20 HLA-A(*)02:01 Restricted Minor Histocompatibility Antigens
por: Romaniuk, Dmitrii S., et al.
Publicado: (2019)

Characterization of the novel HLA‐DQA1*02:01:14 allele by sequencing‐based typing
por: Cargou, Marine, et al.
Publicado: (2022)

Characterization of the novel HLA‐DPA1*02:01:21 allele by sequencing‐based typing
por: Cargou, Marine, et al.
Publicado: (2022)

HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease
por: Hosseini, Ehteramolsadat, et al.
Publicado: (2023)

HLA-DRB1∗16:01 and HLA-DQB1∗05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma
por: Wang, Xu, et al.
Publicado: (2021)

Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study
por: Manca, Maria Antonietta, et al.
Publicado: (2023)

Identification of the novel HLA‐C*07:02:01:115 allele in a volunteer bone marrow donor
por: Ulrich, Silvia, et al.
Publicado: (2021)

HLA Alleles B(*)53:01 and C(*)06:02 Are Associated With Higher Risk of P. falciparum Parasitemia in a Cohort in Uganda
por: Digitale, Jean C., et al.
Publicado: (2021)

Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control
por: Murakoshi, Hayato, et al.
Publicado: (2018)

CD8(+) T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
por: Hensen, Luca, et al.
Publicado: (2021)

The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population
por: Huang, Jieting, et al.
Publicado: (2016)

Early peanut introduction wins over the HLA-DQA1*01:02 allele in the interplay between environment and genetics
por: Manohar, Monali, et al.
Publicado: (2022)

Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes
por: Kuse, Nozomi, et al.
Publicado: (2021)

HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature
por: Liao, Jin-Mao, et al.
Publicado: (2023)

Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires
por: Scholz, Erika Margaret, et al.
Publicado: (2017)

Characterization of a novel HLA-A*11:335 allele resulting from a rare interlocus recombination involving HLA-A*11:01:01:01/126 and HLA-H*02:07/14/18 alleles with nanopore sequencing, in a volunteer from the China Marrow Donor Program
por: Zhang, Li-Qun, et al.
Publicado: (2022)

Understanding CD8(+) T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope
por: Nguyen, Thi HO, et al.
Publicado: (2017)

Hemizygous amplification and complete Sanger sequencing of HLA‐C*07:37:01:02 from a South European Caucasoid
por: Asenjo, Judit, et al.
Publicado: (2020)

Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B*15:02 and HLA-A*31:01 Across Diverse Ancestral Backgrounds
por: Buchner, Amanda, et al.
Publicado: (2021)

CERN Bulletin Issue No. 01-02/2015
Publicado: (2015)

EXM 91-01: 28.02.91
por: Daems, G
Publicado: (1991)

EXM 91-01: 28.02.91
por: Deams, G
Publicado: (1991)

Challenging immunodominance of influenza-specific CD8(+) T cell responses restricted by the risk-associated HLA-A*68:01 allomorph
por: van de Sandt, C. E., et al.
Publicado: (2019)

Corrigendum: Validation of single nucleotide variant assays for human leukocyte antigen haplotypes HLA-B*15:02 and HLA-A*31:01 across diverse ancestral backgrounds
por: Buchner, Amanda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_061jmege0o0k6uo3qcmebt6od9